![](/img/cover-not-exists.png)
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
Anene,, Bentley,, Broder, Michael, Ortendahl, Jesse, Juday, Timothy, Correll, ToddLanguage:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S47486
Date:
September, 2013
File:
PDF, 726 KB
english, 2013